Drugs / LPS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03953196 | Apr → Dec 2019 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LPS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03953196 ↗ |
| Route | Intravenous | “administered as single IV injection” NCT03953196 ↗ |